Nobel Prize, Clinical Trials and More…

Surfing the web, I found these stories of interest:

    • The National Cancer Institute released a video on Patient Safety in Clinical Trials:

      • According to ScienceDaily, the University of Virginia School of Medicine has administered the first dose of an experimental immunotherapy for pediatric acute lymphoblastic leukemia. The clinical trial participant was a 14 year old patient.
      • As reported in the New York Times, American Scientists Jeffrey Hall, Michael Rosbash, and Michael Young won the 2017 Nobel Prize for Physiology for Medicine for their discoveries of molecular mechanisms controlling our biological clocks.

 

 

Zika, MacSpec Pen and More…

Read on for some of the latest developments in cancer research.

  • Researchers say that after conducting early animal studies, the Zika virus, which is a serious health threat especially to unborn children, could help treat brain cancer.
  • Scientists and engineers at the University of Texas at Austin have invented a powerful tool called the MacSpec Pen that rapidly and accurately identifies cancerous tissue during surgery, delivering results in about 10 seconds—more than 150 times as fast as existing technology. Read more about this device in Science Translational Medicine.
  • ASCO released a strategic plan designed to promote the development of a culturally competent oncology workforce that is equipped to care for the diverse population of patients with cancer. The plan is now published in the Journal of Clinical Oncology.